Biocon Biologics Limited - Company Profile

It is a pharma public limited company based in Bengaluru, Karnataka, India, established in 2016.
2016 Bengaluru, Karnataka, India Active
Last Updated:
Access Report
About Biocon Biologics Limited

Biocon Biologics Limited, a active public limited company, was established on 08 June 2016 in Bengaluru, Karnataka, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24119KA2016PLC093936. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹3,500.00 Cr and a paid-up capital of ₹1,819.87 Cr.

Formerly known as Biocon Biologics India Limited. It upholds a compliant status. Employing 5,280 professional, Its leadership includes Bobby Kanubhai Parikh (Director), Kiran Mazumdar Shaw (Whole-Time Director), Daniel Mark Bradbury (Director). Past directors included Bobby Kanubhai Parikh, John Russell Fotheringham Walls, Kiran Mazumdar Shaw. It holds ₹9,543.66 Cr open charges and ₹18,987.20 Cr settled loans. Its latest AGM occurred on 25 July 2025, with the balance sheet filed on 31 March 2025. It is based at Biocon House, Ground Floor, Tower-3, Semicon Park Electronic City, Phase - Ii, Hosur Road, Bengaluru, Karnataka, 560100.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24119KA2016PLC093936

  • Registration Number

    093936

  • Incorporation Date

    08 June 2016

  • Authorized Capital

    ₹3,500.00 Cr

  • Paid-Up Capital

    ₹1,819.87 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3,500.00 Cr
  • Paid Up Capital ₹ 1,819.87 Cr
  • Company Age 9 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 9,543.66 Cr
  • Satisfied Charges ₹ 18,987.20 Cr
  • Revenue Growth **** -7.73%
  • Profit Growth **** -617.79%
  • Ebitda **** -170.56%
  • Net Worth 691.55%
  • Total Assets **** 209.36%
Company report

Biocon Biologics Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Biocon Biologics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Biocon Biologics Limited?
Current Directors
Name Designation Appointment Date Status
Bobby Kanubhai Parikh Director 01 Aug 2019 Current
Kiran Mazumdar Shaw Whole-Time Director 08 Jun 2016 Current
Daniel Mark Bradbury Director 01 Aug 2019 Current
Rajiv Malik Nominee Director 29 Nov 2022 Current
Peter Baron Piot Director 21 Jan 2021 Current
Shreehas Pradeep Tambe Ceo 05 Dec 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 24 Jul 2020 Past
Pramod Abcsdd Director 07 Jun 2024 Past
Pramod Abcsdd Director 21 Jan 2021 Past
Pramod Abcsdd Company Secretary 15 Mar 2019 Past
Pramod Abcsdd Cfo(Kmp) 23 Oct 2019 Past
Pramod Abcsdd Additional Director 24 Jul 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Biocon Biologics.

Biocon Biologics Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.73% decrease. The company also saw a substantial fall in profitability, with a 617.79% decrease in profit. The company's net worth Soared by an impressive increase of 691.55%.

Biocon Biologics revenue growth over time
Biocon Biologics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -7.73%
*******
*******
*******
*******
Revenue from Operations
*******
 -11.43%
*******
*******
*******
*******
Total Assets
*******
 209.36%
*******
*******
*******
*******
Profit or Loss
*******
 -617.79%
*******
*******
*******
*******
Net Worth
*******
 691.55%
*******
*******
*******
*******
EBITDA
*******
 -170.56%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Biocon Biologics?

In 2023, Biocon Biologics had a promoter holding of 92.04% and a public holding of 7.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹95,436,558,080.00

Satisfied Charges

₹189,872,015,000.00

Charges Breakdown by Lending Institutions
  • Others : 9543.66 Cr
Latest Charge Details
Date Lender Amount Status
09 Dec 2024 Others ₹2,734.90 Cr Open
22 Nov 2024 Others ₹6,808.76 Cr Open
06 Mar 2023 The Hongkong And Shanghai Banking Corporation Limited ₹9,841.76 Cr Satisfied
03 Mar 2023 Others ₹7,947.94 Cr Satisfied
13 Sep 2021 Others ₹200.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Biocon Biologics?

Biocon Biologics has a workforce of 5280 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Biocon Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biocon Biologics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Biocon Biologics
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Biocon Biologics Limited last Annual general meeting of members was held on 25 Jul 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Biocon Biologics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.

  • Charges

    A charge registered on 03 Mar 2023 via Charge ID 100692461 with Others was fully satisfied on 09 Jan 2025. was recorded as a recent event.

  • Charges

    The activity A charge registered on 30 Oct 2020 via Charge ID 100386601 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 07 Jan 2025. was completed.

  • Charges

    Progress on A charge registered on 14 Dec 2018 via Charge ID 100224925 with Others was fully satisfied on 06 Jan 2025. was documented.

  • Charges

    A charge with Others of Rs. 2,734.90 Cr registered on 09 Dec 2024 with Charge ID 101019160 was modified on 30 Dec 2024. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Biocon Biologics Limited?

The CIN of Biocon Biologics Limited is U24119KA2016PLC093936.

Where is Biocon Biologics Limited headquartered?

Biocon Biologics Limited is headquartered at Biocon House, Ground Floor, Tower-3, Semicon Park Electronic City, Phase - Ii, Hosur Road, Bengaluru, Karnataka, 560100.

When was Biocon Biologics Limited incorporated?

Biocon Biologics Limited was incorporated on 08 June 2016.

Who are the current directors of Biocon Biologics Limited?

The current directors of Biocon Biologics Limited are

What is the primary industry of Biocon Biologics Limited?

The primary industry of Biocon Biologics Limited is Manufacturing.

Is Biocon Biologics Limited a listed company?

Biocon Biologics Limited is unlisted.

What is the capital structure of Biocon Biologics Limited?

The authorized capital of Biocon Biologics Limited is ₹3,500.00 Cr, and the paid-up capital is ₹1,819.87 Cr.

What is the compliance status of Biocon Biologics Limited?

The compliance status of Biocon Biologics Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available